$190.65
Value $303B
MS and TRMK stock compared: price, dividend, valuation and results, from SEC filings.
$190.65
Value $303B
$47.88
Value $2.8B
Morgan Stanley (MS) has a market value of $303B and Trustmark (TRMK) $2.8B. Over the last year, with dividends, MS moved +14.7% and TRMK +26.8%. The P/E is 15.3 for MS and 12.0 for TRMK. Dividend yield: MS 2.26%, TRMK 2.07%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
MS$303B
TRMK$2.8B
MS is 107 times TRMK
Revenue, 12 months
MS$80.2B
TRMK$822M
MS is 97 times TRMK
Net income, 12 months
MS$20.5B
TRMK$236M
MS is 87 times TRMK
Operating margin
MS–
TRMK–
ROIC
MS4.4%
TRMK11.1%
6.7 points apart
P/E
MS15.3
TRMK12.0
MS is 1.3 times TRMK
Dividend yield
MS2.3%
TRMK2.1%
0.2 points apart
5-year return
MS+123.5%
TRMK+63.7%
59.8 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
MS+123.5%
TRMK+63.7%
| Period | MSWith dividends | TRMKWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +14.7%Price +12.2% | +26.8%Price +23.8% |
| 3 years since November 13, 2023 | +176.8%+40.4% a yearPrice +154.1% | +145.7%+34.9% a yearPrice +126.4% |
| 5 years since November 12, 2021 | +123.5%+17.5% a yearPrice +90.9% | +63.7%+10.4% a yearPrice +41.4% |
| 10 years since November 15, 2016 | +530.5%+20.2% a yearPrice +376.6% | +100.0%+7.2% a yearPrice +48.8% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
MSMorgan StanleyTRMKTrustmark
| Price | $190.65 | $47.88 |
|---|---|---|
| Market value | $303B | $2.8B |
| Enterprise value (EV) | – | – |
| P/E | 15.3 | 12.0 |
| P/E, 5-year median | 15.8 | 10.5 |
| P/B | 2.6 | 1.4 |
| EV/EBIT | – | – |
| Free cash flow yield | – | – |
| Revenue, 12 months | $80.2B | $822M |
|---|---|---|
| Net income, 12 months | $20.5B | $236M |
| Free cash flow, 12 months | – | – |
| Earnings per share, 12 months | $12.60 | $3.99 |
| Revenue growth, year on year | 14.4% | 42.6% |
| Revenue growth a year, past | +7.7%over 5 years | +2.7%over 5 years |
| EPS growth a year, past | +9.6%over 5 years | +8.1%over 5 years |
| Gross margin | – | – |
|---|---|---|
| Operating margin | – | – |
| Net margin | 25.5% | 28.7% |
| ROIC | 4.4% | 11.1% |
| ROE | 18.0% | 11.1% |
| Cash | $244B | – |
|---|---|---|
| Total debt | $378B | $172M |
| Net debt / EBITDA | – | – |
| Interest cover | – | – |
| Dividend yield | 2.3% | 2.1% |
|---|---|---|
| Dividend per share, 12 months | $4.30 | $0.99 |
| Dividend growth a year, past | – | +0.9%over 5 years |
| Buyback yield | 1.5% | 2.8% |
| Shareholder yield | 3.8% | 4.9% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Morgan Stanley ($303B) is about 107.4 times Trustmark ($2.8B), at today's prices.
Since November 15, 2016, MS's price moved +376.6% and TRMK's +48.8%. With dividends: MS +530.5% (+20.2% a year), TRMK +100.0% (+7.2% a year). Past returns do not predict future ones.
The dividend yield at today's price is 2.26% for Morgan Stanley and 2.07% for Trustmark. Over the last twelve months they paid $4.30 and $0.99 per share.
At today's price, the P/E is 15.3 for MS and 12.0 for TRMK. The median of the last five years was 15.8 and 10.5, which shows where each stands against its own past.
Over the last twelve months, the net margin was 25.5% for Morgan Stanley and 28.7% for Trustmark, and the operating margin – and –. Revenue was $80.2B and $822M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.